SG Americas Securities LLC Sells 308,835 Shares of Surgery Partners, Inc. $SGRY

SG Americas Securities LLC reduced its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 54.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 258,141 shares of the company’s stock after selling 308,835 shares during the period. SG Americas Securities LLC’s holdings in Surgery Partners were worth $3,077,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of SGRY. Caitong International Asset Management Co. Ltd boosted its position in Surgery Partners by 45,640.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after acquiring an additional 2,282 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Surgery Partners by 128.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock worth $58,000 after acquiring an additional 1,519 shares in the last quarter. Aquatic Capital Management LLC purchased a new position in shares of Surgery Partners in the 3rd quarter valued at approximately $121,000. Tower Research Capital LLC TRC lifted its stake in shares of Surgery Partners by 68.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock valued at $207,000 after purchasing an additional 3,794 shares during the period. Finally, Prudential Financial Inc. bought a new stake in shares of Surgery Partners during the second quarter valued at approximately $219,000.

Analysts Set New Price Targets

Several brokerages recently weighed in on SGRY. Jefferies Financial Group reaffirmed a “buy” rating and issued a $17.00 price target on shares of Surgery Partners in a research note on Wednesday, May 6th. Mizuho decreased their price target on shares of Surgery Partners from $19.00 to $17.00 and set an “outperform” rating for the company in a research note on Thursday, March 5th. TD Cowen dropped their price objective on shares of Surgery Partners from $28.00 to $20.00 and set a “buy” rating on the stock in a research note on Thursday, March 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Surgery Partners in a report on Tuesday, May 26th. Finally, UBS Group reissued a “buy” rating on shares of Surgery Partners in a research report on Wednesday, March 11th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.18.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $16.80 on Wednesday. The business has a fifty day moving average price of $14.31 and a 200-day moving average price of $14.36. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.86 and a quick ratio of 1.69. The company has a market capitalization of $2.20 billion, a PE ratio of -28.00, a PEG ratio of 4.95 and a beta of 1.96. Surgery Partners, Inc. has a 1-year low of $11.41 and a 1-year high of $24.10.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Tuesday, May 5th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.12. The company had revenue of $810.90 million for the quarter, compared to the consensus estimate of $797.69 million. Surgery Partners had a negative net margin of 2.28% and a positive return on equity of 1.04%. Surgery Partners’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.04 EPS. As a group, equities analysts expect that Surgery Partners, Inc. will post 0.25 EPS for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.